ALT Altimmune, Inc.
$2.99▲ +1.01%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$581.48M
P/E Ratio
–
Div Yield
–%
52W Range
2.56 - 6.44
% vs 50 MA
-2.17%
% vs 200 MA
-25.51%
RSI-14
44.1
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.50
Gross Rev
$36,000
Gross Profit
-$66.05M
EBITDA
-$96.10M
COGS
$66.09M
Operating Exp
$30.05M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.66 · 51 posts
DiscussionTradeRobinhood Onchain?
r/wallstreetbets · Jul 9, 2026
The author suggests a potential 'alt season' driven by Robinhood Chain, referencing altcoins.
positive
+0.80
DiscussionTradeAstrology + Crypto ?
r/wallstreetbets · Jul 6, 2026
Referring to ‘alt coin season’ is a positive sentiment, indicating potential growth opportunities for altcoins.
positive
+0.40
DDDiscussionIALT - alt that goes up and to the right
r/investing · May 13, 2026
The post highlights impressive risk-adjusted returns and expresses excitement about the investment opportunity.
positive
+0.80
NewsEarningsTradeDDEarnings play
r/wallstreetbets · May 2, 2026
The post highlights a positive funding round and upcoming catalysts, indicating potential for a stock bounce.
positive
+0.70
DDTradeMeme$5K YOLO on Altimmune ($ALT)
r/wallstreetbets · Jan 23, 2026
The author expresses excitement about the company's potential and mentions a positive aspect (weight loss drug), indicating bullish sentiment.
positive
+0.60
Page 1 of 11 (51 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.